Beth Israel Deaconess Medical Center in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital.

There are 673 beds in Beth Israel Deaconess Medical Center.

During the past decade, Beth Israel Deaconess Medical Center conducted 920 clinical trials. In the 10-year time frame, 920 clinical trials started and 619 clinical trials were completed, i.e. on average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 390 clinical trials started and 300 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center" #1 sponsor was "Beth Israel Deaconess Medical Center" with 387 trials, followed by "Dana-Farber Cancer Institute" with 183 trials sponsored, "Massachusetts General Hospital" with 101 trials sponsored, "National Cancer Institute (NCI)" with 96 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 96 trials sponsored. Other sponsors include 1183 different institutions and companies that sponsored additional 555 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center" #1 collaborator was "Beth Israel Deaconess Medical Center" with 196 trials as a collaborator, "National Cancer Institute (NCI)" with 165 trials as a collaborator, "Brigham and Women's Hospital" with 122 trials as a collaborator, "Massachusetts General Hospital" with 96 trials as a collaborator and "Dana-Farber Cancer Institute" with 59 trials as a collaborator. Other collaborators include 1784 different institutions and companies that were collaborators in the rest 696 trials.

According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Medical Center" are "Breast Cancer" (95 trials), "HIV Infections" (94 trials), "Prostate Cancer" (57 trials), "Multiple Myeloma" (47 trials) and "Lung Cancer" (32 trials). Many other conditions were trialed in "Beth Israel Deaconess Medical Center" in a lesser frequency.

Most popular intervention types in "Beth Israel Deaconess Medical Center" are "Drug" (1276 trials), "Other" (272 trials), "Biological" (250 trials), "Device" (243 trials) and "Procedure" (148 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (197 trials), "Nivolumab" (54 trials), "Laboratory Biomarker Analysis" (51 trials), "Bevacizumab" (43 trials) and "Paclitaxel" (35 trials). Other intervention names were less common.

The vast majority of trials in "Beth Israel Deaconess Medical Center" are 1796 trials for "All" genders, 148 trials for "Female" genders and 79 trials for "Male" genders.

Currently, there are 567 active trials in "Beth Israel Deaconess Medical Center". 8 are not yet recruiting, 271 are recruiting, 281 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 1129 completed trials in Beth Israel Deaconess Medical Center, 9 suspended trials, and 211 terminated clinical trials to date.

Out of the total trials that were conducted in Beth Israel Deaconess Medical Center, 334 "Phase 1" clinical trials were conducted, 778 "Phase 2" clinical trials and 395 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 387 trials that are defined as “Not Applicable".

Beth Israel Deaconess Medical Center has several departments that took part in Clinical trials: "Beth Israel Deaconess Med Ctr; Hem/Onc" - 4 trials, "Beth Israel Comprehensive Cancer Center" - 4 trials, "Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine" - 3 trials, "Beth Israel Deaconess Med Ctr; Neurology/MS Center" - 3 trials, "Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center" - 3 trials, "Beth Israel Deaconess Medical Center/ Massachusetts Mental Health Center" - 2 trials, "Pain Clinic at Beth Israel Deaconess Medical Center" - 2 trials, "Douglas Plesko" - 2 trials